Impact NKI research highlighted by ASCO


Research led by Lisette Rozeman was selected by the American Society of Clinical Oncology for inclusion in the Clinical Cancer Advances 2020, which highlights the most impactful research advances of the past year.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.